Worthington Mark

EDGAR CIK 0001861464

Athira Pharma, Inc. - ATHA

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer
GENERAL COUNSEL
Direct Buys
0
$0
0 Shares
Direct Sells
2
($8,448)
-4,937 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/05/2024
09/05/2024
Sell
-2,525 @ $0.57
 ($1,429) 51,927 (-4.64%) Direct
01/05/2024
02/16/2024
Sell
-2,412 @ $2.91
 ($7,019) 34,452 (-6.54%) Direct